Tramadol Exposures Reported to Statewide Poison Control System

Author:

Marquardt Kathy A1,Alsop Judith A2,Albertson Timothy E3

Affiliation:

1. Kathy A Marquardt PharmD DABAT, Senior Toxicology Management Specialist, California Poison Control System, Sacramento Division; Associate Clinical Professor of Pharmacy, Division of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco; Clinical Professor of Medicine, Section of Medical Toxicology and Clinical Pharmacology, Division of Pulmonary and Critical Care, Department of Internal Medicine, University of California Davis School of Medicine, Sacramento, CA

2. Judith A Alsop PharmD DABAT, Managing Director, California Poison Control System, Sacramento Division; Associate Clinical Professor of Pharmacy, Division of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco; Clinical Professor of Medicine, Section of Medical Toxicology and Clinical Pharmacology, Division of Pulmonary and Critical Care, Department of Internal Medicine, University of California Davis School of Medicine

3. Timothy E Albertson MD MPH PhD, Medical Director, California Poison Control System, Sacramento Division; Professor of Medicine, Anesthesiology, Pharmacology/Toxicology, and Emergency Medicine, Division of Pulmonary and Critical Care Medicine, Departments of Internal Medicine and Emergency Medicine, School of Medicine, University of California Davis School of Medicine, and the Veterans Affairs Northern California Health Care System

Abstract

BACKGROUND: Tramadol is a unique analgesic that has been associated with seizures on overdose. OBJECTIVE: To determine the toxic effects associated with tramadol exposure. METHODS: A retrospective chart review of tramadol exposures reported to a multisite, state-wide poison control system over a 2.5-year period was performed. RESULTS: A total of 602 cases were retrieved; 190 had sufficient data for study evaluation. Cases with coingestants or unknown outcomes were eliminated. Of the 190 remaining cases, 55% were females. Acute ingestions represented 90.0%, chronic ingestions 7.9%, and acute on chronic 2.1% of the overdoses. Ages of the patients ranged from 9 months to 80 years. Suicide attempts represented the largest group of exposures. Main symptoms included central nervous system (CNS) depression (27.4%), nausea and vomiting (21.1%), tachycardia (17.4%), and seizures (13.7%). Dosage ranged from a taste amount to 5000 mg. The smallest amount of tramadol associated with seizure was 200 mg, and 84.6% of seizures occurred within 6 hours of time of ingestion. Logistic regression analysis showed an association between seizures and tramadol use in males, chronic use, suicide attempts, intentional abuse or misuse, and tachycardia (HR >100 beats/min). No effect was seen in 36.3% of patients, minor effects in 43.7%, moderate effects in 19.5%, and major effects in 0.5%. Symptoms resolved within 24 hours in 96.7% of the 121 patients who had symptoms. Naloxone improved CNS depression in 7 of 8 patients in whom a response was documented. CONCLUSIONS: Tramadol overdoses frequently cause CNS depression, nausea/vomiting, tachycardia, and seizures. Symptoms generally resolve within 24 hours. Accidental ingestions in children were well tolerated, primarily causing sedation.

Publisher

SAGE Publications

Subject

Pharmacology (medical)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3